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Introduction
The integrity of cognitive abilities is vital for old people
to maintain their independence, and any potential risk
factor for cognitive decline against which one could inter-
vene warrants careful evaluation. In recent years it has
been a matter of debate whether the blood pressure status
contributes independently to the impairment of the cogni-
tive function that comes with age. Hypertension has been
associated with atherosclerotic changes in large and small
cerebral blood vessels and a reduction in autoregulation
of cerebral blood flow [1,2], and is a major risk factor 
for strokes and vascular dementia. Clinically ‘silent’ white-
matter lesions in hypertensive subjects have been
observed by neuroimaging and may be associated with
decrements in cognitive functioning [3,4]. Most case–
control studies have reported a functional impairment of
the central nervous system in hypertensive subjects, as
assessed with neuropsychologic tests [5–12], but differ-
ences between hypertensive and normotensive individ-
uals were not observed in all individual tests or in all
studies [13]. The deficiencies that were most consistently
associated with hypertension were found in memory func-
tion, attentional capacity, abstract reasoning, and speed of
response [13–15]. Longitudinal data suggest that cogni-
tive decline over time is more pronounced among hyper-
tensives than it is among normotensive control subjects
[5], although other investigators found no difference in
the rate of change in cognitive scores related to the
subject’s hypertensive status [16,17]. However, from a
clinical perspective the between-group differences are
small and not very specific. 
Population-based studies on this issue have produced
mixed results. In the Framingham Heart Study, 2123
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Can the blood pressure predict cognitive task performance 
in a healthy population sample?
Martin P. J. van Boxtel, Carlo Gaillard*, Peter J. Houx, Frank Buntinx†, 
Peter W. de Leeuw‡ and Jelle Jolles
Objectives To study the relation between the blood
pressure and the neurocognitive function within the full
adult age range in a large population sample.
Design A cross-sectional study of 936 healthy adults
who were recruited from a register of family practices,
stratified for age (24–81 years), sex, and occupational
level, who took part in a medical and neurocognitive test
program.
Methods The blood pressure status was studied in
relation to five measures of cognitive ability, including
verbal memory and speed of information processing.
Other vascular risk factors were treated as control
variables and included smoking, alcohol intake, body
mass index, and body fat distribution. The blood pressure
was measured five times using an automatic recording
technique (with a Dinamap 8100 device).
Results After adjustment for age, sex, and educational
level in a hierarchical regression analysis, we found no
unequivocal association between the mean systolic and
diastolic blood pressures (or any other studied vascular
risk factor) and cognitive test performance both for the
whole group and for the subgroup of subjects who were
not being administered antihypertensive medication and
whose medical history did not include cardiovascular
events. Stratified analysis within four age levels revealed
no age-specific associations between the blood pressure
and the cognitive function. Subjects whose blood
pressure was within the hypertensive range performed
worse than did matched controls at letter digit copying,
but not according to other cognitive measures.
Conclusions With a population-based sample unselected
for blood pressure status we found no linear relationship
between the actual blood pressure level and various
aspects of cognitive performance. Prospective studies
are needed to investigate the possibility that the
systemic blood pressure load over time is associated
with a decline in specific cognitive abilities.
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subjects aged 55–89 years were tested with a short cogni-
tive screening battery [18]. After adjustment for the
effects of age, sex, education, vascular risk factors
(smoking, alcohol intake), and use of antihypertensive
medication, no relation between the diastolic or systolic
blood pressure (measured once or twice) and cognitive
performance scores was found. However, when informa-
tion from previous biennial control visits on the blood
pressure status and use of antihypertensive medication
was taken into consideration, an inverse relation between
the cognitive compound score on the one hand, and the
proportion of blood pressure measurements within the
hypertensive range and overall mean systolic and diastolic
blood pressures on the other was found for subjects who
had not been treated with antihypertensive medication
[19]. Reanalysis of these data revealed an inverse relation
between historical mean blood pressure levels and the
overall cognitive performance [20]. The midlife level of
the systolic – but not diastolic – blood pressure in the
4678 surviving male members of the Honolulu–Asia Aging
Study (mean age 78 years) was related negatively to the
score in a cognitive screening test 25 years later, inde-
pendently of age, education, cardiovascular disease, and
subclinical atherosclerosis [2]. In a recent Italian study,
the diastolic – but not systolic – blood pressure level in
1339 subjects aged 65–95 years was associated with cogni-
tive impairment [a Mini-Mental Status Examination
(MMSE) score below 24] but only among subjects aged
75 years and over, after the authors had controlled for 
age, sex, education, depressive symptomatology, and anti-
hypertensive treatment [21]. The subjects in that study
were free from neurologic diseases but included in their
number institutionalized subjects: nearly 30% of the study
group consisted of cognitively impaired people (MMSE
score < 24). By taking pathologic cognitive decline as an
outcome measure, it was demonstrated recently in a longi-
tudinal study of 382 nondemented subjects who were
aged 70 years at baseline that higher systolic and dias-
tolic blood pressures were associated with the develop-
ment of dementia 10–15 years later [22]. However, the
authors of that study did not control for the educational
level and socioeconomic status of their subjects, which
factors may affect the risks both of hypertension and of
dementia, and thereby mediate the association between
hypertension and dementia. Finally, in a large cross-
sectional study of 1642 subjects aged 75–101 years an
inverse association between the blood pressure and
dementia was demonstrated [23].
The issue becomes more complex when the factor age is
considered. It has been suggested that the blood pressure
accounts for the variance in measures of cognitive perfor-
mance that otherwise would be ascribed simply to aging
[24]. The prevalence both of hypertension and of cogni-
tive impairment rises with age. Conversely, the cerebral
blood flow is known to decline markedly with age, and
the structural changes in the brain associated with hyper-
tension may cause cerebral ischemia [1], thereby aggra-
vating the age-related cognitive decline indirectly [3,8].
On the other hand, some evidence from cross-sectional
studies [2,18,24] indicates that an elevated blood pressure
is beneficial for the cognitive status of older subjects by
promoting cerebral blood flow. Thus, because the preva-
lence of vascular risk factors (including a blood pressure
within the hypertensive range) and the development of
vascular pathology and end-organ damage are related intri-
cately to age and sex, it is important to control these
variables in any study of the relation between vascular
risk factors and the cognitive function. This study was
intended to examine the relation between the repeatedly
measured blood pressure and the performance in tests of
global and specific cognitive functioning with a large adult
population sample, with rigorous adjustment for the
factors age, sex, and educational background. Other
vascular risk factors (smoking behavior, alcohol intake,
body mass index, and fat distribution) were included in
the analysis as potentially confounding variables [25].
Methods
Subjects
The study population consisted of 943 subjects who
participated between March 1993 and February 1995 in
the Maastricht Aging Study (MAAS) [26]. This cohort of
community-dwelling adults was recruited in two waves
from a register of 15 local family practices that contained
60 000 patients [27]. Registration as a patient of a general
practice is compulsory in The Netherlands so that each
citizen is administered medical care and therefore the
register can be considered an unselected population
sample. The subjects were invited to take part in the
study in an introductory letter from their general practi-
tioners. The first half of the study sample was drawn from
the group of 3744 subjects that had been recruited 
from the register, in order to satisfy the requirements of
a postal survey into health and memory-related functions.
This group was stratified for sex and age (into 12 classes,
of subjects aged 25 ± 1 years, 30 ± 1 years, and so on up
to 80 ± 1 years, each of at least 310 subjects). Of this group
2362 (63.1%) subjects agreed to participate and 2043
(54.6%) returned the postal questionnaire in good order:
1252 (33.4%) of these respondents volunteered for an
additional medical and cognitive test program, for which
468 subjects were selected randomly, again stratified for
sex, age class, and, additionally, two levels of occupational
achievement. The latter procedure was intended to
stratify beforehand the level of general ability [26]. For
the second wave a group of 2047 subjects was selected
from the register in order to replicate the first-wave study
exactly, using the same design and methodology, but
without an independent postal survey. Of this group 676
(33.0%) subjects agreed to participate in the test program,
of whom 475 were actually tested. The remainder of the
volunteers were included in a third wave of the MAAS,
which is not described here. Data for seven subjects for
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whom we had incomplete cognitive data were excluded
from the analysis, which resulted in a final sample size of
936.
Participating and nonparticipating groups did not differ
with respect to the number of medical problems and the
presence of chronic diseases recorded by their general
practitioners. Noncomplying subjects in the first step of
recruitment were found more often in the youngest and
oldest age classes, were less well educated, and were more
often women [26].
Subjects with past or present morbidity generally associ-
ated with brain dysfunction, namely overt cerebrovascular
disease (including those who had suffered a stroke),
chronic neurologic diseases (e.g. dementia, epilepsy, and
Parkinson’s disease), mental retardation, and psychotropic
drug use, were not included. This reduced the eligible
population in the register by 4%. In addition, subjects
who had been invited to participate in the test program
were screened for possible dementia with the MMSE [28].
Thirteen subjects who scored below the clinical cut-off
score of 24 were excluded before entering the test
program. Subject characteristics are summarized in Table
1. The study protocol was approved by the ethics com-
mittee of the Academic Hospital, Maastricht, and all of
the participants gave their informed consent to partici-
pate in the study.
Measurements
Background characteristics
The questionnaire that was filled in by all of the partici-
pants covered background characteristics, including edu-
cation (on an eight-point scale, ranging from primary
education to university degree [29]) and an extensive
health history. A structured medical interview preceded
the actual test session, to check the questionnaire inform-
ation and the eligibility for the study. Tobacco use and
alcohol intake were scored as dichotomous variables
[present or past smoking: yes/no; alcohol intake of less/
more than 21 (women) or 35 (men) standard units per week
[30]). More specifically, subjects with medically confirmed
cardiovascular morbidity [a cardiovascular event (CVE),
including angina pectoris, cardiac arrhythmia, myocardial
infarction, cardiac insufficiency, valvular lesions, heart
surgery, resuscitation, and evidence of peripheral athero-
sclerosis] and those who were being administered anti-
hypertensive medication were identified. The prevalence
of these characteristics is shown in Table 1.
Physical measurements
The body height and weight of each subject were
measured to calculate the body mass index (BMI, in
kg/m2). In addition, the waist and hip circumference was
determined, the waist : hip ratio (WHR) being used as an
independent vascular risk factor [31]. During the 30 min
intermission between two test blocks the blood pressure
was recorded five times, with fixed intervals of 5 min.
Measurements were made on the left arm with a Criti-
kon Dinamap 8100 monitor (Critikon, Tampa, Florida, 
USA) that was equipped with the appropriately sized arm 
cuff. During blood pressure measurements the subjects
were seated, did not smoke or drink caffeine-containing
beverages and were left unattended by the researcher
after careful instruction. The averages of five consecutive
measurements was taken as the habitual systolic and dias-
tolic blood pressures.
Cognitive assessment
Standard neuropsychologic tests were used to assess the
cognitive domains general intelligence, memory, sensori-
motor speed, and information processing speed/cognitive
flexibility [26], which are described briefly below.
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Table 1 Main independent and dependent variables used in this study, by levels of age (regrouped into six classes) and sex
(presented cognitive outcome measures are population-based, Z-transformed scores)
Age class (years) Sex
25–30 35–40 45–50 55–60 65–70 75–80 Men Women
(n = 161) (n = 162) (n = 162) (n = 159) (n = 162) (n = 130) (n = 475) (n = 461)
Men/women 81/80 81/81 80/82 81/78 81/81 71/59
Diastolic blood pressure (mmHg) 67 ± 8 71 ± 10 75 ± 10 76 ± 11 76 ± 11 76 ± 12 76 ± 10 71 ± 11
Systolic blood pressure (mmHg) 119 ± 11 120 ± 11 126 ± 14 133 ± 17 142 ± 19 147 ± 21 133 ± 17 128 ± 20
Hypertension* 5 11 23 39 67 62 118 89
Waist : hip ratio 0.81 ± 0.08 0.84 ± 0.09 0.86 ± 0.10 0.88 ± 0.08 0.90 ± 0.08 0.90 ± 0.07 0.91 ± 0.07 0.81 ± 0.08
Body mass index (kg/m2) 24.8 ± 3.9 25.6 ± 3.8 27.0 ± 5.5 27.1 ± 3.6 27.9 ± 4.1 27.6 ± 3.5 26.7 ± 4.0 26.5 ± 4.6
Smokers (past/actual) 87 124 123 102 98 88 365 257
High alcohol intake (actual) 3 7 9 8 1 4 14 18
Antihypertensive drug use 1 1 16 26 51 59 76 78
CVE 1 6 7 25 48 57 92 52
CVE/antihypertensive drug use 2 7 18 39 74 76 119 97
Memory 0.56 ± 0.76 0.47 ± 0.76 0.10 ± 0.78 0.01 ± 0.84 −0.40 ± 0.91 −0.91 ± 0.87 −0.26 ± 0.95 0.27 ± 0.87
Sensorimotor speed 0.65 ± 0.43 0.47 ± 0.45 0.25 ± 0.54 −0.08 ± 0.64 −0.47 ± 0.69 −1.00 ± 0.81 −0.01 ± 0.79 0.03 ± 0.82
Cognitive flexibility 0.67 ± 0.45 0.51 ± 0.53 0.28 ± 0.65 −0.09 ± 0.67 −0.49 ± 0.76 −1.13 ± 0.89 −0.04 ± 0.87 0.07 ± 0.89
Letter/Digit Substitution Test 0.90 ± 0.70 0.56 ± 0.74 0.25 ± 0.78 −0.19 ± 0.71 −0.63 ± 0.78 −1.12 ± 0.72 −0.08 ± 0.96 0.08 ± 1.03
Word fluency 0.42 ± 0.94 0.31 ± 0.94 0.18 ± 0.97 −0.15 ± 0.97 −0.31 ± 0.97 −0.57 ± 0.82 −0.03 ± 1.01 0.03 ± 0.99
Values are expressed as means ± SD and numbers of subjects. *Diastolic blood pressure > 90 mmHg or systolic blood pressure > 140 mmHg. 
CVE, cardiovascular event.
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Four subtests of the Groningen Intelligence Test (GIT)
were used to obtain an estimation of the full-scale intel-
ligence quotient [32].
The Word Learning Task (WLT) is based upon the
Auditory Verbal Learning Test [33] and evaluates the
ability to acquire and retain new verbal information. A set
of 15 frequently used monosyllabic words is presented in
fixed order at a rate of one every 2 s in each of five trials.
After every trial the subject is asked to reproduce the
memorized words (immediate recall). Twenty minutes
after the last trial the subject is asked again to reproduce
the set of words (delayed recall). The total of correctly
reproduced words during five trials, the maximum score
in five trials, and the number of correctly reproduced
words after 20 min are recorded.
The Concept Shifting Task (CST) is a test of behavioral
planning and is analogous to the Trail-Making-Test of
the Army Individual Test Battery [34]. The subject’s
ability to alternate two psychologic concepts during task
performance is measured (i.e. number and letter cancel-
lation in correct order). A test sheet contains 16 small-
diameter (15 mm) circles arranged in a larger circle
(diameter 16 cm). Two null versions (part 0) contain no
symbols in the circles, the number version (part A)
presents the numbers 1–16 in random order in the circles,
a letter version (part B) depicts randomly the letters A–P,
and finally a number–letter version (part C) alternates the
numbers 1–8 and letters A–H. The subject is instructed
to cross out the circles in correct order, as fast as possible
without making errors. The outcome is the time needed
to complete each task.
Susceptibility to perceptual interference was measured by
using the Stroop Color Word Test (SCWT), consisting of
three subtasks; color word naming (I), color naming (II),
and naming of color words printed in a different color
(interference task III). This test detects robust effects of
chronologic age [35].
The Letter/Digit Substitution Test (LDST) is a modi-
fied version of the paper-and-pencil Symbol Digit
Modalities Test [36] and measures the basic information-
processing speed. The subject is requested to copy
numbers in cells that are indexed by a letter. The letter
refers to nine letter–number pairs in a key at the top of
the form. The total number of corresponding numbers
correctly copied in 90 s is recorded.
Word Fluency was scored as the total number of animal
names reproduced correctly in 60 s [32]. The test reflects
the organizational level among clusters of meaningful
related words.
Data reduction and analysis
To limit the number of dependent variables and to
improve the robustness of the underlying cognitive
construct [37,38], the relevant raw test scores were clus-
tered in three compound performance indices, labelled
memory, cognitive flexibility, and sensorimotor speed.
Raw scores were transformed to standardized Z scores 
for the total group [Z = (X – X
–
)/SD]. Next, we averaged
Z scores from tests that had been included in the com-
pound performance index: the memory score was derived
from the total, maximal, and delayed recall scores of 
the WLT; the cognitive flexibility score included the 
C version of the CST and subtask III of the SCWT [39];
and the sensorimotor speed was calculated from the 0, A,
and B versions of the CST, and subtask I of the SCWT.
Thus, the memory score was calculated as (ZWLTTOT +
ZWLTMAX + ZWLTDEL)/3, the cognitive flexibility score as 
− (ZCST-C + ZSCWT-III)/2, and the sensorimotor speed score
as − (ZCST-0 + ZCST-A + ZCST-B + ZSCWT-I)/4. The signs of
the speed and flexibility scores were made negative 
to make them reflect above-average performance when
positive and below-average performance when negative.
LDST and fluency test outcomes were also transformed
to Z-scores but not included in compound scores because
the performance in these tests is less domain-specific.
Multiple hierarchical regression analysis was used to esti-
mate the strength of associations between predictor vari-
ables and the performance in cognitive outcome measures.
After we had controlled for chronological age, sex, and
education in the first step, the various vascular risk factors
and their respective age–risk-factor interaction terms with
age were entered as pairs in the regression models in order
to detect an increase in explained variance in cognitive
performance measures. The predictor variables tested
were the systolic and diastolic blood pressures, BMI,
WHR, alcohol intake, smoking behavior, antihypertensive
drug use, and presence of CVE in the medical history.
Separate models were fitted for the total group and for
the group of subjects free from CVE and not being admin-
istered antihypertensive medication (n = 720).
Next, subjects were classified hypertensive when they had
a diastolic blood pressure > 90 mmHg or a systolic blood
pressure > 140 mmHg [40]. All of the hypertensive
subjects thus identified were matched for age (in years),
sex, and educational level with normotensive controls.
Between-group differences were tested with Student’s
paired t tests. P < 0.05 was considered statistically signif-
icant, unless indicated otherwise
Results
Table 1 provides descriptive statistics of the predictor
variables and the cognitive outcome measures, by levels
of age, class, and sex.
Zero-order correlations between predictor variables and
cognitive outcome measures are presented in Table 2. All
of the cognitive parameters were correlated negatively to
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age (from −0.34 to −0.68), and positively, but to a lesser
extent, with the educational level (0.35–0.48) and general
intelligence (0.11–0.36). The relatively high correlations
of cognitive parameters to educational level may in part
be explained in terms of the −0.39 correlation between
age and education. The systolic and diastolic blood
pressures, BMI, WHR, antihypertensive medication use,
and CVE in the medical history were also related nega-
tively to cognitive scores, but again such associations can
be mediated by the factor age.
The associations between vascular risk factors and the
risk factor–age interaction with the five cognitive scores
(memory, sensorimotor speed, cognitive flexibility, letter
digit copying, and fluency), were tested in separate
multiple hierarchical regression analyses, after we had
adjusted for age, sex, and educational level. When the
BMI, WHR, smoking, alcohol intake, antihypertensive
medication use, and CVE in the medical history were
entered together with their respective interaction-
with-age term in the regression models, no significant
additional variance in cognitive outcome measures was
explained by these factors. For this reason these variables
were not included as control variables in the final models
in which the blood pressure and the blood pressure–age
interaction were tested as predictors of the cognitive
outcome.
The separate models fitted for the diastolic and systolic
blood pressures showed that the variables chronological
age, sex, and educational level explained between 17%
(word fluency) and 50% (letter/digit copying) of the vari-
ance in cognitive scores, age being the most important
predictor. No association between the blood pressure and
cognitive parameters was observed in the models after
step 2. However, in the model for the systolic blood
pressure the age–blood pressure interaction term was asso-
ciated negatively with two speed indices, the sensorimotor
speed and cognitive flexibility. There was no noticeable
change in the size and direction of the observed effects
when the entry of blocks was reversed and age was
entered in the last block of variables, or when the analyses
were repeated for the subgroup of subjects with no history
of CVE and not being administered antihypertensive
drugs. Table 3 summarizes the results of regression
analysis for the systolic blood pressure both for the total
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Table 2 Zero–order correlations among age, sex, educational level, vascular risk factors and cognitive parameters
Sensori
Intelligence motor Cognitive 
Age Sex† quotient Education Memory speed flexibility LDST Fluency
Age −0.50* −0.67* −0.65* −0.68* −0.34*
Sex −0.02 0.28* 0.03 0.06 0.08 0.03
Intelligence quotient 0.12* −0.21* 0.11* 0.24* 0.27* 0.27* 0.36*
Education −0.39* −0.07 0.48* 0.35* 0.46* 0.47* 0.48* 0.36*
Diastolic blood pressure 0.26* −0.25* 0.07 −0.10* −0.17* −0.17* −0.16* −0.21* −0.11*
Systolic blood pressure 0.55* −0.13* 0.07 −0.24* −0.30* −0.40* −0.38* −0.41* −0.21*
Pulse pressure 0.51* 0.02 0.05 −0.21* −0.26* −0.38* −0.37* −0.37* −0.18*
Body mass index 0.24* −0.03 −0.05 −0.20* −0.17* −0.16* −0.18* −0.18* −0.10*
Waist : hip ratio 0.36* −0.55* 0.10* −0.18* −0.35* −0.26* −0.27* −0.30* −0.18*
Alcohol intake‡ −0.01 0.03 0.04 0.04 0.03 0.02 0.03 0.03 0.04
Smoking behavior‡ 0.01 −0.22* 0.10* −0.02 −0.09* 0.03 0.01 0.01 0.05
Antihypertensive medication‡ 0.41* 0.01 0.03 −0.14* −0.22* −0.28* −0.27* −0.30* −0.17*
Cardiovascular events‡ 0.40* −0.11* 0.11* −0.10* −0.26* −0.23* −0.25* −0.26* −0.10*
*P > 0 .01 (two-tailed test). LDST, Letter/Digit Substitution Test. †0, male; 1, female; ‡0, no, 1, yes
Table 3 Results of multiple hierarchical regression analyses of cognitive outcome variables
Step 1 Step 2 R2 after step
Age Sex Education SBP Age × SBP 1 2
All subjects
Memory −0.40*** 0.30*** 0.21*** 0.05 −0.08* 0.331*** 0.336*
Sensorimotor speed −0.57*** 0.05* 0.24*** 0.03 −0.11*** 0.478*** 0.487***
Cognitive flexibility −0.54*** 0.10*** 0.28*** 0.03 −0.10*** 0.485*** 0.493***
Letter/digit copying −0.55*** 0.09*** 0.26*** −0.01 −0.02 0.498*** 0.499
Word fluency −0.22*** 0.06 0.28*** 0.00 −0.03 0.173*** 0.174
CVE/medication-free subjects
Memory −0.35*** 0.29*** 0.25*** 0.02 −0.07* 0.302*** 0.306
Sensorimotor speed −0.54*** 0.05 0.25*** 0.00 −0.11*** 0.456*** 0.467***
Cognitive flexibility −0.51*** 0.11*** 0.31*** −0.02 −0.10*** 0.489*** 0.499***
Letter/digit copying −0.50*** 0.09** 0.26*** −0.05 −0.03 0.466*** 0.469
Word fluency −0.21*** 0.08** 0.28*** 0.03 −0.02 0.157*** 0.158
Shown are standardized regression coefficients (b), the significance level of the unstandardized regression coefficient (B) in the final model, 
R2 (the proportion of explained variance), and the significance of the change in R2 after each step. Different models were fitted for all subjects 
(n = 936) and for subjects free from cardiovascular events and not being administered antihypertensive drugs (n = 720). *P < 0.05, **P < 0.01,
***P > 0.001. SBP, systolic blood pressure; CVE, cardiovascular event.
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group and for the selection of subjects free from CVE
who had not been administered antihypertensive drugs
(n = 720). Results for the diastolic blood pressure are not
shown here but were virtually identical up to step 1.
The contribution of the blood pressure to the regression
models was small (it explained at most 1.0% of the addi-
tional variance in the cognitive flexibility score, for the
systolic blood pressure in subjects of the unmedicated
and CVE-free group). However, the observed age–systolic
blood pressure interactions suggested that there was an
age-dependency in the blood pressure–cognitive perform-
ance relationship. It was therefore decided to perform
identical regression analyses for the data in four age strata:
25–35 years, 40–50 years, 55–65 years, and 70–80 years.
No association between the systolic blood pressure and
any of the five cognitive variables was observed for any
age stratum, using the same adjustments for background
variables as in earlier analyses.
In an attempt to replicate earlier findings of cognitive
deficits in patient groups with clinical hypertension, the
subjects whose blood pressure was within the hyper-
tensive range, on the basis of the mean of laboratory
values, were matched with normotensive controls for
calendar age, sex, and educational level. Of 207 thus-
identified hypertensive subjects (diastolic blood pressure
> 90 mmHg or systolic blood pressure > 140 mmHg
[40]), 191 were matched in this way. The cognitive scores
of this subgroup were again rescaled to a Z distribution:
the two groups are compared in Table 4. Paired Student’s
t tests revealed a higher mean BMI for the group with
hypertension. Furthermore, hypertensive subjects per-
formed worse at letter/digit copying, but no significant
between-group differences were observed with other
cognitive measures.
Discussion
Vascular risk factors were studied in relation to several
aspects of cognitive performance in an adult population,
stratified for age, sex, and general ability. This was done
in order to separate the effect on cognitive processes of
factors that may be linked to cerebrovascular pathology
from the effect of primary aging. We found weak inverse
associations between the age–systolic blood pressure
interaction term on the one hand, and two measures of
the information-processing speed (the sensorimotor speed
and cognitive flexibility) on the other. Neither the blood
pressure status nor any other vascular risk factor, however,
was associated with the cognitive performance, after we
had accounted for the variance explained by age, sex, and
educational level. The same observation was made after
age-stratified analysis: again the blood pressure status 
did not explain unique variance, indicating that there 
was no age-dependent relationship between the blood
pressure and cognitive test scores. Finally, hypertensive
subjects performed worse at letter/digit copying than did
age-, sex-, and education-matched controls with normal
blood pressures, which partly confirms earlier observations
of cognitive performance deficits in hypertensive indi-
viduals. However, we found no other between-group
differences in cognitive outcome. Before any conclusions
can be drawn several methodologic issues need to be
addressed.
Blood pressure measurement
To determine the blood pressure status accurately we
measured the blood pressure in a standard environment
[41]. More importantly, the blood pressure was measured
in the absence of an observer to minimize the response
of the blood pressure in some individuals which might
have occurred as a result of an alerting reaction (the white-
coat effect [42]). In this respect, single or duplicate blood
pressure measurement by classical sphygmomanometry is
particularly error-prone, because an observer is present to
record the blood pressure. Nevertheless, sphygmo-
manometry has been used in most of the studies reviewed
here [4,18,20,43], which might have resulted in estimates
of the habitual blood pressure less precise than those in
this study.
However, averaging all five consecutive blood pressure
measurements does not take into account that the blood
pressure tends to habituate during a measurement
interval. Indeed, subjects who had been screened in the
first wave of this study tended to have lower blood
pressures at the end of the 20 min measurement session
[44]. It was suggested that the habitual blood pressure
was reflected better by the average of the final two
measurements. For this reason additional post-hoc
analyses were performed using the averages of the last
two systolic and diastolic blood pressure measurements,
reflecting the blood pressure after adaptation, as predic-
tors of performance. The resulting regression models
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Table 4 Characteristics of subjects whose blood pressure 
was within the hypertensive range (diastolic blood pressure 
> 90 mmHg or systolic blood pressure > 140 mmHg, n = 191)
compared with normotensive controls from this sample,
matched for chronological age, sex, and educational level 
(78 subjects in both groups were female)
Control Hypertensive 
group group
Age (years) 63.1 ± 12.7 63.1 ± 12.7
Education 2.8 ± 1.6 2.8 ± 1.6
Intelligence quotient 115.7 ± 13.5 113.9 ± 13.1
Body Mass Index (kg/m2) 27.2 ± 3.6 28.2 ± 3.9*
Waist : hip ratio 0.90 ± 0.07 0.91 ± 0.07
Diastolic blood pressure (mmHg) 70.0 ± 8.9 84.7 ± 10.2***
Systolic blood pressure (mmHg) 124.6 ± 8.9 155.2 ± 15.9***
Memory 0.02 ± 0.93 −0.01 ± 0.96
Sensorimotor speed 0.05 ± 0.82 −0.03 ± 0.76
Cognitive flexibility 0.12 ± 0.84 −0.02 ± 0.86
Letter/digit copying 0.09 ± 1.03 −0.10 ± 0.96*
Word fluency 0.07 ± 0.93 −0.07 ± 1.06
Values are expressed as means ± SD. Cognitive measures are expressed as
population-based, Z-transformed scores. *P < 0.05, **P < 0.01, ***P < 0.001.
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were, however, not substantially different from those
based on the average of five measurements.
Cognitive status measurement
We chose to combine raw test scores into compound
measures of the neurocognitive function that had been
employed in earlier research. Although this choice was
based on theoretical and statistical considerations, this
procedure might seem to some extent arbitrary in the
choice of variables measuring the same underlying cogni-
tive ability. It could therefore be important to note here
that post-hoc analyses of the raw scores derived from the
cognitive tests as the outcome measures produced essen-
tially the same results as did the analyses of compound
measures.
Blood pressure and the cognitive function
Earlier research suggested that the educational level of a
subject can moderate the association between the blood
pressure and the cognitive performance [45]. We found
no evidence with our sample that the relationship
between the blood pressure and the cognitive function
was education-dependent: the blood pressure–educational
level interaction term was not predictive of the cognitive
outcome in any model (post-hoc analysis, results not
shown). However, the educational level of the participants
was higher than that of nonparticipants, which could have
attenuated cognitive differences between groups with
high and low mean blood pressures in the study sample,
if there were any.
Subjects with manifest neurological diseases or MMSE
scores below 24 were not subjected to the test program,
because the MAAS does not focus primarily on pathologic
cognitive dysfunctions, such as dementia. Instead we
intended to identify determinants of normal (or ‘usual’)
cognitive aging. Results from a recent study by Cacciatore
et al. [21] showed that, for a much older sample (subjects
aged 65–95 years) with evidently more true cognitive
pathology (30% scored below the MMSE cut-off score of
24), an elevated diastolic blood pressure was related to
lower scores on the MMSE. These findings would suggest
that defining our population as we did prevented our
finding an association between the blood pressure and the
cognitive function due to a ‘restriction of range’ with
respect to cognitive abilities and vascular pathology.
However, when studying usual cognitive aging it is impor-
tant to exclude subjects with possible dementia because
it is still not known whether usual cognitive aging and
dementia are on the same continuous scale [46].
It could be argued that, in some respects, the cross-
sectional nature of this study could compromise the gener-
alizability of our findings. The blood pressure status was
based on repeated blood pressure measurements during
a single session and no reliable information was available
about the subjects’ blood pressure status on previous occa-
sions in order to estimate the systemic blood pressure
‘load’ over time. This notion is important in the light of
earlier findings that in fact the blood pressure load, rather
than the blood pressure level at the time of cognitive
testing, was associated with cognitive decline in later life
[2,20]. The actual blood pressure level is at best only a
weak predictor of the lifetime blood pressure load, partic-
ularly when therapeutic intervention has preceded the
measurement. Furthermore, selective participation of
individuals whose vascular system has remained relatively
uncompromised, who may therefore have a lower risk of
cognitive impairment, might have biased our sample. Bias
of this kind could obscure the true impact of an elevated
blood pressure on the cognitive performance and reduce
the generalizability of our findings. It is reassuring in this
respect that participants did not differ from nonpartici-
pants with regard to prevalent morbidity recorded by the
family physician [26]. These limitations, however, apply
to any cross-sectional study on this subject and can be
overcome only by using a longitudinal study design.
Our data do not corroborate the findings of Elias et al.
[24], who, in a study of 301 healthy subjects, aged 20–72
years, found negative correlations between systolic and
diastolic blood pressures within the normal-to-hyper-
tensive range and performances in complex cognitive
tests, after adjustment for age, sex, and educational level.
Subjects with hypertension were encouraged by their
physicians to participate in the study, which could have
resulted in the proportion of hypertensive individuals
being larger than that in the present study. Indeed, as
Elias et al. [24] pointed out, there may be subtle neuro-
cognitive differences between hypertensive and normo-
tensive individuals, but we found no relationship in our
study between the performance in cognitive tests and the
blood pressure treated as a continuous variable.
The presence of cardiovascular disease has been associ-
ated with cognitive deficits in some studies [6,9].
Administration of antihypertensive medication and CVE
both index a wide variety of different vascular morbidity
subtypes. It seems obvious that excluding subjects with
one or more of these characteristics from the analysis
would reduce the prevalence of vascular pathology in the
remaining group, including the prevalence of subclinical
cerebrovascular damage. However, neither administration
of antihypertensive medication nor CVE was associated
with the cognitive function in this study, suggesting that
the impact of such conditions on cognitive abilities is
small in an independently living sample.
In conclusion, the evidence we found of cognitive distur-
bances as a function of the blood pressure status is at best
weak: one index of the information-processing speed (the
LDST) indicated a lower performance among hyper-
tensive subjects, but we found no linear relationship
between the mean blood pressure level and the cognitive
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outcome. From these data we can not conclude that the
actual blood pressure level is an important mediator of
cognitive dysfunctions in a normal aging population unse-
lected with respect to the blood pressure status. Further
research needs to focus on longitudinal follow-up of
cohorts such as this to test the hypothesis that the decline
in function in specific cognitive domains is a function of
the blood pressure ‘load’ over time in more detail.
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